REGN5381 in Adult Participants With Uncontrolled Hypertension

NCT06833190 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Uncontrolled Hypertension

Interventions

DRUG: REGN5381
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals